The Association between Metformin and the Cancer-Specific Mortality Rate in Nasopharyngeal Cancer Patients: Real-World Evidence.

Published in: Current oncology (Toronto, Ont.) (2023)

We concluded that Metformin might be effective at reducing the cancer-specific mortality rate in nasopharyngeal cancer patients. Further randomized control trials should be completed.

Keyphrases

papillary thyroid
squamous cell
cardiovascular events
risk factors
open label
double blind
clinical trial
type diabetes
squamous cell carcinoma
childhood cancer